TrialJournal of gynecologic oncology2022

Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01).

Ji Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.